Cautious on Yahoo! ...
Health Care: Drugs
Sucampo Pharmaceuticals Inc. A (SCMP: NASDAQ)
$8.85 0.23 | 2.67%
05/23/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 4.84M | -17.31M | -2.76M | -760.00K |
| Operating Gains/Losses | 0.00 | 12.00K | 1.00K | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 1.18M | -5.10M | -164.00K | 2.46M |
| (Increase) Decrease in Inventories | 87.00K | -127.00K | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -1.45M | 2.87M | 893.00K | 1.73M |
| (Decrease) Increase In Other Current Liabilities | 15.00K | 523.00K | 3.33M | -3.26M |
| (Increase) Decrease In Other Working Capital | -1.07M | -725.00K | -5.71M | -4.37M |
| Other Non-Cash Items | 26.88M | -26.15M | 1.26M | 14.00K |
| Net Cash From Continuing Operations | 12.00M | -19.99M | -3.35M | -800.00K |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 12.00M | -19.99M | -3.35M | -800.00K |
| Sale of Property, Plant & Equipment | 0.00 | 25.00K | 5.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -3.44M | -3.28M | -333.00K | -3.41M |
| Acquisitions | 0.00 | 0.00 | -28.12M | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 26.14M | 44.38M | -14.90M | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -589.00K | 27.90M | -11.86M | -35.46M |
| Issuance of Debt | 0.00 | 0.00 | 12.08M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 331.00K | 106.00K | 14.00K | 19.00K |
| Repayment of Long-Term Debt | -7.50M | -7.50M | 0.00 | 0.00 |
| Repurchase of Capital Stock | -1.28M | -700.00K | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | -13.73M | 0.00 |
| Other Financing Charges, Net | 0.00 | 13.00K | 0.00 | 0.00 |
| Net Cash From Financing Activities | -8.45M | -8.08M | -1.64M | 19.00K |
| Effect of Exchange Rate Changes | -1.60M | 1.59M | 4.66M | 388.00K |
| Net Change in Cash & Cash Equivalents | 1.36M | 1.42M | -12.18M | -35.85M |
Portfolios with SCMP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- UserGFNN Stockdiagnostics 5
- User©SUPRATRADE HOT STOCKS (...
Latest SCMP Headlines from TheStreet
- Sucampo Pharmaceuticals Inc. A Stock Upgraded (SCMP) 04.18.13 | 05:04 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 5 Stocks Under $10 Triggering Breakouts 03.14.13 | 01:03 pm
- Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Sucampo Pharmaceuticals Inc. A Stock Downgraded (SCMP) 03.12.13 | 05:03 am
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- TheStreet Ratings Top 10 Rating Changes 01.14.13 | 10:01 am
- Sucampo Pharmaceuticals Inc. A Stock Upgraded (SCMP) 01.14.13 | 04:01 am
- Sucampo Pharmaceuticals Inc. A Stock Upgraded (SCMP) 10.29.12 | 05:10 am
- 5 Stocks Poised for Breakouts 09.28.12 | 01:09 pm
Press Releases for SCMP
- Sucampo Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2012 Financial And Operating Results - Business Wire 03.13.13 | 05:03 pm
- Sucampo Pharmaceuticals Announces Fourth Quarter And Full Year 2012 Financial Results And Operating Highlights Teleconference And Webcast - Business Wire 03.06.13 | 06:03 am
- Sucampo Appoints Barbara A. Munder And Maureen E. O’Connell To Board Of Directors - Business Wire 03.01.13 | 06:03 am
- Sucampo Announces Commercial Availability Of RESCULA In U.S. Pharmacies - Business Wire 02.19.13 | 08:02 pm
- Sucampo Files Patent Infringement Lawsuit Against Anchen Pharmaceuticals And Par Pharmaceuticals - Business Wire 02.08.13 | 06:02 am
- Sucampo Pharmaceuticals To Present At Investment Conferences - Business Wire 02.06.13 | 06:02 am
- Sucampo Announces Japanese Government Funding For Unoprostone Isopropyl Development In Retinitis Pigmentosa - Business Wire 02.04.13 | 06:02 am
- Sucampo Pharmaceuticals Announces Webcast Of Its Presentation At The Biotech ShowcaseTM 2013 Conference - Business Wire 01.03.13 | 06:01 am
- Sucampo Announces FDA Approval Of An SNDA For RESCULA® (unoprostone Isopropyl) - Business Wire 12.12.12 | 06:12 am
- Sucampo Receives $15 Million Milestone Payment From Abbott On First Sale Of AMITIZA® (lubiprostone) In Japan - Business Wire 12.11.12 | 06:12 am
Partner Headlines for SCMP
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- Phase 3 Long-Term Safety Trial Results of Lubiprostone in Patients with Irritable Bowel Syndrome with Constipation was Recently Published in Alimentary Pharmacology and Therapeutics - Benzinga 03.06.12 | 04:03 pm
- Life Sciences Companies Raise Record Amounts of Capital - Seeking Alpha 12.31.10 | 04:12 pm
